查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1757608

基因轉移技術的全球市場

Gene Delivery Technologies
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 370 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球基因轉移技術市場規模將達到49億美元

全球基因轉移技術市場規模預計在2024年為30億美元，預計到2030年將達到49億美元，2024年至2030年的複合年成長率為8.7%。生物模式是本報告分析的細分市場之一，預計其複合年成長率為10.3%，到分析期結束時規模將達到32億美元。化學模式細分市場在分析期間的複合年成長率預計為5.8%。

美國市場規模估計為 8.055 億美元，中國市場預計複合年成長率為 13.9%

美國基因轉移技術市場規模預計2024年達到8.055億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到11億美元，在2024-2030年的分析期間內，複合年成長率為13.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.3%和8.4%。在歐洲，預計德國市場的複合年成長率為5.8%。

全球基因轉移技術市場—主要趨勢與促進因素摘要

為什麼基因轉移技術是現代治療和基因組醫學的核心？

基因遞送技術作為基因治療、基因組編輯和個人化醫療的基本推動者，正在徹底改變生物醫學研究和臨床治療的模式。這些技術有助於將遺傳物質（如 DNA、RNA 或 CRISPR-Cas 系統）安全有效地引入目標細胞，這一過程對於糾正基因缺陷、調節基因表現或創建疾病模型至關重要。隨著人們對遺傳疾病、癌症和病毒感染的興趣日益濃厚，對可靠的基因傳遞平台的需求也激增。與傳統藥物不同，基於基因的干涉措施需要精準、有針對性的遞送才能有效且安全，因此增加了病毒載體（例如腺結合病毒、慢病毒、逆轉錄病毒）和非病毒方法（例如脂質奈米顆粒、電穿孔和基於聚合物的系統）的重要性。依賴脂質遞送的 COVID-19 mRNA 疫苗最近取得成功，進一步檢驗了基因遞送工具的商業性和治療可行性，並引發了前所未有的研究資金和跨行業合作。

有哪些新技術可以提高基因轉殖的安全性、精確度和擴充性？

技術創新大大提高了基因傳遞系統的能力，解決了過去的局限性，例如免疫抗原性、轉染效率和組織特異性。在病毒載體中，新一代衣殼工程腺結合病毒(AAV) 具有更好的趨向性並降低了免疫反應，使全身應用對於血友病、視網膜營養不良和脊髓性肌肉萎縮等疾病更加安全。慢病毒載體以其整合到宿主基因組中而聞名，正在針對幹細胞和 CAR-T 細胞療法進行最佳化。在非病毒方面，脂質奈米顆粒 (LNP) 已迅速成為前沿，提供高效率、模組化設計和低毒性，尤其是在基於 mRNA 的療法中。電穿孔和基於微流體的系統在體外應用中越來越受歡迎，尤其是在自體細胞療法中。此外，目前正在研究能夠響應pH值、酶或外部觸發因素（例如光和超音波）的智慧遞送平台，以改善位點特異性基因釋放。這些創新不僅可以改善治療效果，還能支援符合GMP標準的大規模生產，這對於臨床和商業性部署至關重要。

臨床流程、監管趨勢和產業投資將發揮什麼作用？

腫瘤學、神經病學和罕見疾病領域基因療法臨床管線的快速擴張是基因傳遞技術市場的關鍵催化劑。隨著美國FDA 和 EMA 等監管機構加快審查程序以獲得突破性療法認定，數十種基於基因的治療方法正處於臨床開發的後期階段。這種監管勢頭鼓勵新興企業、生技公司和大型製藥公司加強對確保安全性、可重複性和長期療效的遞送平台的投資。遞送技術開發商和治療公司之間的合併、許可協議和研發合作激增表明，遞送系統正被視為戰略資產，而不是技術副業。此外，監管指導越來越重視載體表徵、生物分佈和免疫分析。同時，包括國家基因組任務和特定疾病基金會在內的公共和私人資助計劃正在支持以遞送為重點的研究，以解決服務不足的疾病和人群，進一步擴大全球市場機會。

推動基因轉殖技術全球擴張的關鍵成長要素有哪些？

全球基因遞送技術市場的成長受到臨床創新、治療需求和生物技術進步等若干相互關聯的因素所驅動。最重要的是，基因治療臨床試驗和核准的數量正在增加，這實質上需要針對特定疾病目標和患者群體量身定做的強大且擴充性的遞送機制。其次，基因治療適應症的範圍不斷擴大，從單病性疾病到複雜的癌症和感染疾病，需要開發多樣化且適應性強的遞送平台。第三，合成生物學和基因組工程的進步擴大了對精準遞送系統的需求，這種系統可以容納更大的有效載荷、多重基因編輯和嚴格控制的表現圖譜。第四，政府和私部門對基因醫學的投資不斷增加，正在加速這些平台的開發和商業化。最後，基於 mRNA 的療法和疫苗的成功證明了非病毒遞送系統的市場潛力，刺激了奈米粒子工程、聚合物科學和共軛化學的進一步創新。總的來說，這些因素支持基因傳遞技術作為下一代醫學的基礎支柱在全球強勁擴張。

部分

模式（生物模式、化學模式、物理模式）、方法（體外法、體內法、離體法）、應用（基因治療應用、細胞治療應用、疫苗應用、研究應用）

受訪公司範例（總合34家）

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • American Gene Technologies
  • AskBio（subsidiary of Bayer AG）
  • Astellas Gene Therapies
  • Beam Therapeutics Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioNTech SE
  • Bluebird Bio Inc.
  • Catalent, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine Inc.
  • ElevateBio
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • GenScript ProBio
  • Horizon Discovery Ltd.
  • Intellia Therapeutics Inc.
  • Johnson & Johnson

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36988

Global Gene Delivery Technologies Market to Reach US$4.9 Billion by 2030

The global market for Gene Delivery Technologies estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Biological Mode, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Chemical Mode segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$805.5 Million While China is Forecast to Grow at 13.9% CAGR

The Gene Delivery Technologies market in the U.S. is estimated at US$805.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global "Gene Delivery Technologies" Market - Key Trends & Drivers Summarized

Why Are Gene Delivery Technologies at the Core of Modern Therapeutics and Genomic Medicine?

Gene delivery technologies are revolutionizing the landscape of biomedical research and clinical treatment, serving as the fundamental enablers for gene therapy, genome editing, and personalized medicine. These technologies facilitate the safe and efficient introduction of genetic material-DNA, RNA, or CRISPR-Cas systems-into target cells, a process essential for correcting genetic defects, modulating gene expression, or creating disease models. With the surge in interest surrounding genetic diseases, cancers, and viral infections, the demand for reliable gene delivery platforms has skyrocketed. Unlike traditional pharmaceuticals, gene-based interventions require precise and targeted delivery to be effective and safe, thus elevating the importance of both viral vectors (like adeno-associated virus, lentivirus, and retrovirus) and non-viral methods (such as lipid nanoparticles, electroporation, and polymer-based systems). The recent success of mRNA vaccines for COVID-19, which relied on lipid-based delivery, has further validated the commercial and therapeutic viability of gene delivery tools, sparking unprecedented research funding and cross-industry collaborations.

How Are Emerging Technologies Enhancing Safety, Precision, and Scalability in Gene Delivery?

Technological innovation is dramatically advancing the capabilities of gene delivery systems, addressing past limitations in immunogenicity, transfection efficiency, and tissue specificity. In viral vectors, new-generation adeno-associated viruses (AAVs) with engineered capsids are offering improved tropism and reduced immune responses, making them safer for systemic applications in diseases like hemophilia, retinal dystrophies, and spinal muscular atrophy. Lentiviral vectors, known for their integration into host genomes, are being optimized for stem cell and CAR-T cell therapies. On the non-viral front, lipid nanoparticles (LNPs) have surged to the forefront, especially in mRNA-based therapies, offering high efficiency, modular design, and low toxicity. Electroporation and microfluidic-based systems are gaining traction for ex vivo applications, particularly in autologous cell therapies. Additionally, smart delivery platforms responsive to pH, enzymes, or external triggers (e.g., light or ultrasound) are being explored to improve site-specific gene release. These innovations not only enhance therapeutic outcomes but also support large-scale, GMP-compliant manufacturing-critical for clinical and commercial deployment.

What Role Do Clinical Pipelines, Regulatory Trends, and Industry Investment Play?

The rapid expansion of gene therapy clinical pipelines across oncology, neurology, and rare diseases is a key catalyst for the gene delivery technologies market. Dozens of gene-based therapies are in advanced stages of clinical development, with regulatory bodies such as the U.S. FDA and EMA accelerating review pathways for breakthrough designations. This regulatory momentum is encouraging startups, biotech firms, and pharma giants alike to intensify investment in delivery platforms that ensure safety, reproducibility, and long-term efficacy. Mergers, licensing deals, and R&D collaborations between delivery tech developers and therapeutic companies have spiked, signaling a growing recognition of delivery systems as strategic assets rather than technical afterthoughts. Additionally, regulatory guidance is now increasingly emphasizing vector characterization, biodistribution, and immune profiling-areas directly tied to delivery mechanism design. Meanwhile, public and private funding initiatives, including national genomics missions and disease-specific foundations, are supporting delivery-focused research to address underserved diseases and populations, further expanding global market opportunities.

What Are the Key Growth Drivers Fueling the Global Expansion of Gene Delivery Technologies?

The growth in the global gene delivery technologies market is driven by several interconnected factors stemming from clinical innovation, therapeutic demand, and biotechnological advancement. Foremost is the increasing number of gene therapy trials and approvals, which inherently require robust and scalable delivery mechanisms tailored to specific disease targets and patient populations. Second, the broadening range of gene therapy indications-from monogenic disorders to complex cancers and infectious diseases-is necessitating the development of diverse and adaptable delivery platforms. Third, advances in synthetic biology and genome engineering are expanding the need for precision delivery systems that can accommodate larger payloads, multiplex gene edits, and tightly regulated expression profiles. Fourth, rising investment from both governments and the private sector in genetic medicine is accelerating platform development and commercialization pathways. Lastly, the success of mRNA-based therapeutics and vaccines has demonstrated the market potential for non-viral delivery systems, spurring further innovation in nanoparticle engineering, polymer science, and conjugation chemistry. These factors collectively underpin the robust global expansion of gene delivery technologies as a foundational pillar of next-generation medicine.

SCOPE OF STUDY:

The report analyzes the Gene Delivery Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Mode (Biological Mode, Chemical Mode, Physical Mode); Method (Ex Vivo Method, In Vivo Method, In Vitro Method); Application (Gene Therapy Application, Cell Therapy Application, Vaccines Application, Research Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • American Gene Technologies
  • AskBio (subsidiary of Bayer AG)
  • Astellas Gene Therapies
  • Beam Therapeutics Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioNTech SE
  • Bluebird Bio Inc.
  • Catalent, Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine Inc.
  • ElevateBio
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • GenScript ProBio
  • Horizon Discovery Ltd.
  • Intellia Therapeutics Inc.
  • Johnson & Johnson

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Gene Delivery Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Viral and Non-Viral Vectors Drive Innovation in Gene Delivery Platforms
    • Rising R&D Investments in Gene Therapies Strengthen Business Case for Delivery Technologies
    • Emergence of mRNA and CRISPR Modalities Throws the Spotlight on Targeted Gene Delivery Systems
    • Clinical Pipeline Expansion in Rare and Genetic Disorders Accelerates Technology Adoption
    • Growing Cell and Gene Therapy Manufacturing Ecosystem Expands Demand for Scalable Delivery Tools
    • Strategic Collaborations Between Biotech and CDMOs Generate Growth in Gene Delivery Outsourcing
    • Regulatory Support for Novel Therapies Spurs Innovation in Safe and Effective Delivery Mechanisms
    • Increased Interest in Tissue- and Cell-Specific Vectors Propels Customization in Delivery Platforms
    • Technological Integration with Nanocarriers and Lipid Particles Expands Functional Capabilities
    • Use of AI and Predictive Models Enhances Precision in Vector Design and Gene Expression Control
    • Rising Investment in In Vivo Delivery for Oncology Applications Sustains Market Momentum
    • Intellectual Property and Licensing Strategies Create Barriers and Competitive Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gene Delivery Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Biological Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Chemical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Physical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Gene Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cell Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ex Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for In Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for In Vitro Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • JAPAN
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • CHINA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: China 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • EUROPE
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • FRANCE
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: France 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • GERMANY
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • INDIA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: India 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
  • AFRICA
    • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030

IV. COMPETITION